88日本消化器病学会雑誌

第119巻

臨時増刊号

The 11th International Forum of The Japanese Society of Gastroenterology
JSGE-IASL（International Association for the Study of the Liver）Joint Session

DAY2
Time ＆ Date：9：00〜17：05, Friday, April 22, 2022
Place：Room 6（3F, Room Grace , Keio Plaza Hotel Tokyo）
Main Theme：Dream of Hepatology
Opening Remarks（9：00〜9：10）
Kwang-Hyub Han（National Evidence-based Healthcare Collaborating Agency,
Republic of Korea）
Enomoto Nobuyuki（First Department of Internal Medicine, Faculty ofMedicine, University of Yamanashi, Japan）
1. HCV：Eradication of HCV death（9：10〜10：10）
Moderators：Jean-Michel Pawlotsky（Department of Virology, Henri Mondor University Hospital,France）
Raymond Chung（Liver Center, GI Division, Massachusetts General Hospital,Harvard Medical School, USA）
Masayuki Kurosaki（Department of Gastroenterology and Hepatology, Musashino
Red Cross Hospital, Japan）
IF1-1
The 11th
International Forum

IF1-2

IF1-3

IF1-4

Impacts of the COVID-19 pandemic on HCV elimination
Jean-Michel Pawlotsky（Department of Virology, Henri Mondor University
Hospital, France）
Problems with HCV treatment㽎Refractory HCV and clinical corses after SVR㽎Michio Imamura（Department of Gastroenterology and Metabolism, Hiroshima
University, Japan）
Mechanisms of hepatocarcinogenesis after HCV cure
Raymond Chung（Liver Center, GI Division, Massachusetts General Hospital,Harvard Medical School, USA）
Strategies towards the eradication of HCV death：Treatment of special
population（prior DAA failure）and the identification of high-risk cases for HCC
after SVR
Masayuki Kurosaki（Department of Gastroenterology and Hepatology,
Musashino Red Cross Hospital, Japan）

2022年 3 月

89

2. HBV：Elimination of HBV infection（10：10〜11：30）
Moderators：Sang Hoon Ahn（Department of Internal Medicine, Institute of Gastroenterology,
Yonsei University College of Medicine, Republic of Korea）
Jia-Horng Kao（Hepatitis Research Center, National Taiwan University Hospital,Taiwan）
Yasuhito Tanaka（Department of Gastroenterology and Hepatology, Faculty of LifeSciences, Kumamoto University, Japan）
IF2-1

IF2-2

IF2-3

IF2-4

IF2-5

3. Steatohepatitis：Elucidation of the mechanism（14：15〜15：00）
Moderators：Jacob George（Storr Liver Centre, The Westmead Institute of Medical Research,
Westmead Hospital and University of Sydney, Australia）
Takumi Kawaguchi（Division of Gastroenterology, Department of Medicine, Kurume
University School of Medicine, Japan）
IF3-1

IF3-2

Impact of MAFLD on Intra- and Extrahepatic Events in Patients with Fatty
LiverTakumi Kawaguchi（Division of Gastroenterology, Department of Medicine,
Kurume University School of Medicine, Japan）
Understanding lean MAFLD：Metabolic flexibility and metabolic adaptation
Jacob George（Storr Liver Centre, The Westmead Institute of Medical
Research, Westmead Hospital and University of Sydney,Australia）

The 11th
International Forum

Update on new HBV drugs in development
Sang Hoon Ahn（Department of Internal Medicine, Insitute ofGastroenterolgoy, Yonsei University College of Medicine,
Republic of Korea）
A novel, small anti-HBV compound reduces HBsAg and HBV DNA bydestabilizing HBV RNA
Yasuhito Tanaka（Department of Gastroenterology and Hepatology, Faculty ofLife Sciences, Kumamoto University, Japan）
Elimination of HBV infection in Taiwan
Jia-Horng Kao（Hepatitis Research Center, National Taiwan University
Hospital, Taiwan）
A novel therapeutic option for HBV elimination using additional
immunomodulatory effects of nucleotide analogs
Kazumoto Murata（Division of Virology, Department of Infection andImmunity, Jichi Medical University, Japan）
What do we need for functional cure of HBV infection?
Henry Lik Yuen Chan
（Union Hospital/The Chinese University of Hong Kong,Hong Kong）

90

日本消化器病学会雑誌

IF3-3

第119巻臨時増刊号

Incidence of CVD in NAFLD/MAFLD patients：a retrospective nationwide
claims database study in Japan.
Masato Yoneda（Department of Gastroenterology and Hepatology, Yokohama
City University, Japan）

4. Cirrhosis：Endeavor for control（15：00〜16：00）
Moderators：Jordi Gracia-Sancho（Liver Vascular Biology, IDIBAPS Biomedical Research Institute＆ CIBEREHD, Spain）
Thomas Berg（Division of Hepatology, Department of Medicine II；Leipzig
University Medical Center, Germany）
Hitoshi Yoshiji（Department of Gastroenterology, Nara Medical University, Japan）
IF4-1

IF4-2

IF4-3

IF4-4The 11thInternational Forum

Portal hypertension in CLD：molecular mechanisms and therapeutic
opportunities
Jordi Gracia-Sancho（Liver Vascular Biology, IDIBAPS Biomedical ResearchInstitute ＆ CIBEREHD, Spain）
CTGF secreted from liver sinusoidal endothelial cells has an essential role inliver fibrosis
Hayato Hikita（Department of Gastroenterology and Hepatology, OsakaUniversity, Graduate School of Medicine, Japan）
The role of G-CSF in the treatment of acute-on-chronic liver failure（ACLF）
Thomas Berg（Division of Hepatology, Department of Medicine II；Leipzig
University Medical Center, Germany）
Liver cirrhosis：endeavor for control in Japan
Hitoshi Yoshiji（Department of Gastroenterology, Nara Medical University,Japan）

5. Hepatocellular Carcinoma：Evolution of the new treatment（16：00〜17：00）
Moderators：Markus Peck-Radosavljevic（Innere Medizin ＆ Gastroenterologie, Klinikum
Klagenfurt, Austria）
Kwang-Hyub Han（National Evidence-based Healthcare Collaborating Agency）
Taro Yamashita（Department of General Medicine, Kanazawa University Hospital,Japan）
IF5-1

IF5-2

Progress in the Treatment of Hepatocellular Carcinoma（HCC）
Markus Peck-Radosavljevic（Innere Medizin und Gastroenterologie, Klinikum
Klagenfurt, Austria）
Recent advances of systemic therapy for hepatocellular carcinoma in Japan
Kaoru Tsuchiya（Department of Gastroenterology and Hepatology, Musashino
Red Cross Hospital, Japan）

2022年 3 月

IF5-3

IF5-4

91

Aequanimitas in the era of evolution of the new treatment for HCC
Kwang-Hyub Han（National Evidence-based Healthcare Collaborating Agency,
Republic of Korea）
Cancer stemness in hepatocellular carcinoma
Taro Yamashita（Department of General Medicine, Kanazawa University
Hospital, Japan）

Closing Remarks（17：00〜17：05）
Markus Peck-Radosavljevic（Innere Medizin ＆ Gastroenterologie, Klinikum
Klagenfurt, Austria）

The 11thInternational Forum